Maropitant (Cerenia) in Dogs & Cats
Generic: Maropitant
Maropitant, commonly sold under the brand name Cerenia, is a potent NK1 receptor antagonist used to prevent and treat vomiting and motion sickness in dogs and cats.
This medication is intended for dogs and cats.
Overview
Maropitant is a specialized antiemetic medication that belongs to the neurokinin-1 (NK1) receptor antagonist class. It is widely recognized in veterinary medicine for its ability to block the binding of substance P, a key neurotransmitter involved in the vomiting reflex. By inhibiting this pathway, it effectively prevents both peripheral and central causes of nausea, making it a cornerstone treatment for various forms of gastrointestinal distress. Unlike older antiemetic options like metoclopramide which act primarily on dopamine receptors, maropitant provides a more targeted and durable effect.
The clinical utility of maropitant is expansive, covering acute gastroenteritis, chemotherapy-induced nausea, and general malaise associated with systemic illness. When pets suffer from severe nausea, it is often difficult to administer oral medications; however, because maropitant is available in an injectable form, veterinarians can provide immediate relief to patients who are actively vomiting. This versatility ensures that even pets with sensitive stomachs can receive the care they need to recover comfortably. It is often used in conjunction with gastric mucosal protectants like sucralfate when treating patients with severe acid reflux or ulcers.
In addition to treating active vomiting, maropitant is uniquely FDA-approved for the prevention of motion sickness. Pet owners often find that administering a dose shortly before travel significantly reduces stress for both the animal and the owner. While common digestive issues may sometimes require the addition of agents like bismuth subsalicylate for diarrhea or temporary motility agents like cisapride for delayed stomach emptying, maropitant remains the gold standard for managing the complex neurological and physical components of vomiting. Its long half-life allows for once-daily dosing, which simplifies compliance for pet owners managing chronic digestive health concerns.
What It Treats
- Acute vomiting: Effectively suppresses the vomiting reflex caused by various systemic or gastrointestinal triggers.
- Motion sickness: Prevents nausea and vomiting induced by vehicular travel in dogs.
- Chemotherapy-induced vomiting: Helps maintain hydration and nutrition in oncology patients undergoing treatment.
- Post-operative nausea: Reduces the risk of vomiting following anesthesia and surgery.
How It Works
Maropitant functions as an NK1 receptor antagonist. In the body, the vomiting center in the brain receives signals from various sources—including the inner ear (motion), the digestive tract, and the blood—via the neurotransmitter substance P. By binding to these NK1 receptors, maropitant effectively 'mutes' the signal to the brain's vomiting center, stopping the reflex at both the peripheral and central levels. Because it blocks the final common pathway for most triggers of vomiting, it is significantly more effective than traditional medications that only target one specific pathway.
Dosage
Dosage varies significantly based on whether the medication is being used for motion sickness, acute vomiting, or the specific species (dog vs. cat). Always follow the exact dosing regimen provided by your veterinarian, as the dosage for motion sickness prevention is typically higher than the dose for simple anti-emetic therapy. Do not alter the frequency or dose without professional veterinary guidance.
Administration
Maropitant can be administered either orally as a tablet or via subcutaneous injection. Tablets should be given with a small amount of food to prevent the medication itself from causing mild nausea on an empty stomach. If administering the injectable form, your veterinarian will handle the procedure to minimize injection site irritation, as the cold temperature of the solution can sometimes cause a temporary stinging sensation.
Storage
Store maropitant tablets and the injectable solution at room temperature, typically between 68°F and 77°F (20°C to 25°C). Keep the medication in a tightly sealed container and out of reach of pets and children. Avoid exposing the medication to excessive heat or moisture, and ensure the injectable vial is stored away from direct sunlight to maintain chemical stability.
Contraindications
Maropitant should be used with caution in pets with pre-existing hepatic (liver) disease, as the liver is the primary site of metabolism for this drug. Because the medication is processed by the liver, prolonged use in animals with impaired hepatic function may lead to toxic accumulation of the drug in the bloodstream. Veterinarians will typically monitor liver enzymes if long-term treatment is required. It is generally contraindicated for use in patients with known gastrointestinal obstructions or suspected ingestion of toxins that the body is attempting to expel through vomiting. If a pet has ingested a foreign body, preventing the vomiting reflex may hinder the natural process of clearing the object or worsen the clinical state of the bowel. Always ensure a definitive diagnosis is reached before masking clinical signs.
Interactions
Maropitant is highly protein-bound and may interact with other medications that share the same metabolic pathways or protein-binding characteristics. Caution should be exercised when administering maropitant concurrently with other drugs that are extensively protein-bound, such as NSAIDs, cardiac drugs like digoxin, or anticonvulsants. Your veterinarian may need to adjust the timing of doses if your pet is on a multi-drug regimen. Additionally, while it is often used in combination with other gastrointestinal medications, it is important to avoid duplicating effects unless directed. Consult your veterinarian before adding supplements or over-the-counter aids such as probiotics or binders to ensure there is no risk of additive adverse effects on the GI tract.
Side Effects
- Lethargy or drowsiness
- Hypersalivation (drooling)
- Decreased appetite
- Diarrhea
- Pain at the injection site
- Muscle tremors in rare instances
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.
